HealthStream Inc provides SaaS based applications for healthcare organizations all designed to improve business and clinical outcomes by supporting the people who deliver patient care... Show more
HSTM saw its Momentum Indicator move above the 0 level on September 29, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 101 similar instances where the indicator turned positive. In 68 of the 101 cases, the stock moved higher in the following days. The odds of a move higher are at 67%.
The Moving Average Convergence Divergence (MACD) for HSTM just turned positive on September 30, 2026. Looking at past instances where HSTM's MACD turned positive, the stock continued to rise in 33 of 54 cases over the following month. The odds of a continued upward trend are 61%.
Following a +2.20% 3-day Advance, the price is estimated to grow further. Considering data from situations where HSTM advanced for three days, in 165 of 297 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
The Aroon Indicator entered an Uptrend today. In 106 of 199 cases where HSTM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 53%.
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HSTM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 53%.
HSTM broke above its upper Bollinger Band on October 01, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 12 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.500) is normal, around the industry mean (7.432). P/E Ratio (40.472) is within average values for comparable stocks, (46.656). Projected Growth (PEG Ratio) (2.857) is also within normal values, averaging (2.133). Dividend Yield (0.005) settles around the average of (0.010) among similar stocks. P/S Ratio (2.711) is also within normal values, averaging (6.065).
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. HSTM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 42 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 97 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HSTM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock better than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of SaaS-based workforce development, research, patient experience solutions
Industry ServicestotheHealthIndustry